Bio-Techne (TECH) Interest Expenses (2009 - 2026)
Bio-Techne's (TECH) quarterly Interest Expenses came in at $26.9 million in Q1 2026, down 41.56% year-on-year from $46.0 million in Q1 2025, and little changed quarter-over-quarter from $26.9 million in Q4 2025.
Bio-Techne (TECH) Interest Expenses (2009 - 2026) Analysis & Trends
Bio-Techne's Interest Expenses history runs 18 years deep, the most recent figure standing at $26.9 million for Q1 2026.
- On a quarterly basis, Interest Expenses fell 41.56% year-over-year to $26.9 million in Q1 2026; TTM through Mar 2026 was $26.9 million, a 41.56% decrease from a year earlier, with the FY2025 full-year figure at $155.0 million, down 79.26% from the prior year.
- Interest Expenses steadied at $26.9 million in Q1 2026 per TECH's latest filing, from $26.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $61.9 million in Q1 2022 and bottomed at -$3.8 million in Q2 2025.
- The 5-year median for Interest Expenses is $46.0 million (2025), against an average of $37.6 million.
- Across the five-year window, Interest Expenses soared 460.15% in 2022 and plunged 185.07% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $57.3 million in 2022, then grew by 0.71% to $57.7 million in 2023, then slipped by 20.48% to $45.9 million in 2024, then sank by 41.36% to $26.9 million in 2025, then decreased by 0.04% to $26.9 million in 2026.
- Per Business Quant, the three latest TECH Interest Expenses figures stand at $26.9 million (Q1 2026), $26.9 million (Q4 2025), and $26.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Bio-Techne | 11.19 Bn | 10.98 Bn | 208.29 Mn | 26.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.91 Mn |
| Mar 31, 2026 | 26.91 Mn |
| Dec 31, 2025 | 26.92 Mn |
| Dec 31, 2025 | 26.92 Mn |
| Sep 30, 2025 | 26.91 Mn |
| Sep 30, 2025 | 26.91 Mn |
| Jun 30, 2025 | -3.83 Mn |
| Jun 30, 2025 | -3.83 Mn |
| Mar 31, 2025 | 46.05 Mn |
| Mar 31, 2025 | 46.05 Mn |
| Dec 31, 2024 | 45.91 Mn |
| Dec 31, 2024 | 45.91 Mn |
| Sep 30, 2024 | 46.20 Mn |
| Sep 30, 2024 | 46.20 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 57.38 Mn |
| Mar 31, 2024 | 57.38 Mn |
| Dec 31, 2023 | 57.73 Mn |
| Dec 31, 2023 | 57.73 Mn |